#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma unspecified histology indolent Factor IX deficiency Neurodermatitis Neuropathy peripheral Uveal melanoma Hepatoblastoma Epstein-Barr virus infection Astrocytoma malignant Albright's disease Mitochondrial DNA depletion Familial amyotrophic lateral sclerosis Pyruvate kinase deficiency anaemia Primary biliary cholangitis Vernal keratoconjunctivitis Gastric cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Basic Information Waldenstrom’s macroglobulinaemia – Treatment Pelizaeus-Merzbacher disease – Treatment Osteosarcoma recurrent – Treatment Turner’s syndrome – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Factor IX deficiency – Treatment Cerebral arteriovenous malformation haemorrhagic Osteosarcoma metastatic – Treatment Angiosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiapride Enomimeran Bjt-778 BRENSOCATIB Coffee Charcoal Pilocarpine Hydrochloride Lanifibranor Letrozole Iodine (123I) Iobenguane DUVELISIB Lavender Oil Cibotercept ATOVAQUONE Dolutegravir Bupivacaine Hydrochloride Milrinone Pp1493 Ferumoxytol Miglustat Vitamin A Bp More therapies…

    Learn about Your Condition

    Guttate psoriasis Liposarcoma metastatic Diabetic retinopathy Breast proliferative changes Pneumonia Hyperoxaluria Nocturia Chronic hepatitis C Pulmonary sarcoidosis Fatty acid oxidation disorder Connective tissue disorder Impaired gastric emptying Dry mouth Cardiomyopathy Varices oesophageal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Marginal zone lymphoma

  • Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Extranodal marginal zone B-cell lymphoma (MALT type)
    • Splenic marginal zone lymphoma
    • Marginal zone lymphoma
    Investigated Drugs:
    • Obinutuzumab
    Germany

  • Study on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Precursor B-lymphoblastic lymphoma
    • Burkitt’s lymphoma
    • Marginal zone lymphoma
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    Germany

  • Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma unspecified histology aggressive
    • Marginal zone lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Odronextamab
    France Germany Italy Poland Spain

  • Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Lisocabtagene Maraleucel
    Austria France Germany Italy Spain Sweden

  • Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Rituximab
    Belgium France Italy Portugal

  • Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma refractory
    • Marginal zone lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Odronextamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia France Germany Italy +2
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!